These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2177366)

  • 21. The role of insulin antibodies in insulin treatment of type I diabetes.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin antibodies--do they matter?
    Walford S
    Neth J Med; 1985; 28 Suppl 1():47-9. PubMed ID: 3892339
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic implications of insulin delivery and the role of immune complexes in diabetic sequelae.
    Charles MA; Ong K; Slater L; Golden M; Arquilla ER
    Diabetes Care; 1982; 5 Suppl 1():88-92. PubMed ID: 6765123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
    Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
    J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the different forms of material reacting with antiinsulin antibodies in the fetal and adult rat.
    Felix JM; Sutter-Dub MT; Legrele C
    Horm Metab Res; 1975 Sep; 7(5):394-9. PubMed ID: 1183918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma insulin-binding capacity of diabetes mellitus patients with labile and stable courses].
    Alekseev IuP; Kliachko VP
    Probl Endokrinol (Mosk); 1975; 21(6):7-10. PubMed ID: 1232999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic response to insulin therapy].
    Saccarello A; De Micheli A; Boeri D; Maiello M
    Clin Ter; 1982 Aug; 102(3):293-308. PubMed ID: 6183045
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cooperative effects during interaction of monoclonal antibodies with insulin dimers].
    Rubtsova MIu; Cherednikova TV; Susova MB; Gavrilova EM; Egorov AM
    Biokhimiia; 1987 Sep; 52(9):1531-8. PubMed ID: 3315010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiotypic and fluorometric analysis of the antibodies that distinguish the lesion of the I-A mutant B6.C-H-2bm12.
    Melino MR; Epstein SL; Sachs DH; Hansen TH
    J Immunol; 1983 Jul; 131(1):359-64. PubMed ID: 6190915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin--binding antibodies in Nigerian diabetic patients.
    Bella AF; Adetuyibi A
    West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between insulin antibodies and the HLA system in a group of type I diabetic patients in Bucharest.
    Ionescu-Tîrgovişte C; Cheţa D; Truia CI; Truia M; Mirodon Z; Ilinca D; Cheţa N; Mincu I
    Med Interne; 1986; 24(1):11-7. PubMed ID: 3704498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
    Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
    Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of binding constants of antibodies fractionated according to their affinity to insulin].
    Karulin AIu; Dikov MM; Egorov AM
    Biokhimiia; 1986 May; 51(5):746-50. PubMed ID: 3518815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].
    Efimov AS; Malyzhev VA; Sakalo EA
    Ter Arkh; 1987; 59(11):15-8. PubMed ID: 3441859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.